retatrutide clinical trials news Retatrutide: A Promising Option for Non-Diabetic Weight Loss in Eli Lilly's Phase 3 data

Understanding your specific reasons helps your healthcare provider tailor the best approach for your situation

Diabetes Care 1996;19:106774

This is due to its antioxidant properties, which can interfere with the oxidative damage that chemotherapy drugs aim to induce in cancer cells

GLP-1s are known to have positive cardiovascular effects, and better control of blood glucose levels through GLP-1 treatment has been shown to limit small blood vessel damage that can lead to health complications such as diabetic retinopathy

There has been a notable increase in the number of patients with T2DM due to the global rise in obesity, driven by sedentary lifestyles and regular consumption of energy-dense diets (Hussain, 2025)